Association between carbonyl stress markers and the risk of acute coronary syndrome in patients with type 2 diabetes mellitus-A pilot study.

Autor: Bora S; Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605 006, India., Adole PS; Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605 006, India. Electronic address: prashant.s@jipmer.edu.in., Motupalli N; Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605 006, India., Pandit VR; Department of Emergency Medicine and Trauma, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605 006, India., Vinod KV; Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605 006, India.
Jazyk: angličtina
Zdroj: Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2020 Nov-Dec; Vol. 14 (6), pp. 1751-1755. Date of Electronic Publication: 2020 Sep 06.
DOI: 10.1016/j.dsx.2020.08.037
Abstrakt: Background and Aims: Carbonyl stress is one of the mechanisms responsible for diabetes and its complications. The study was planned to examine the relationship between carbonyl stress markers and the risk of acute coronary syndrome (ACS) in patients with type 2 diabetes mellitus (T2DM).
Methods: Forty T2DM patients with ACS and forty T2DM patients without ACS participated in this cross-sectional pilot study. Routine biochemical investigations, creatine kinase-total (CK-T), and creatine kinase-MB (CK-MB) levels were estimated. Serum carbonyl stress markers were analysed by enzyme-linked immunosorbent assay. Binary logistics regression was done to determine the predictive value of carbonyl stress markers for ACS.
Results: Fasting plasma glucose, serum total methylglyoxal (MG), methylglyoxal derived hydroimidazolones-1 (MG-H1), and N ε -carboxymethyl-lysine (CML) levels were significantly higher in T2DM patients with ACS than in those without ACS. Serum glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and glyoxalase-1 (GLO1) levels were significantly lower in T2DM patients with ACS than in those without ACS. Fasting plasma glucose level was significantly positively correlated with serum MG (r = 0.441, P < 0.001), CML (r = 0.649, P < 0.001), MG-H1 (r = 0.725, P < 0.001), and negatively correlated with serum GAPDH (r = - 0.268, P = 0.012) and GLO1 (r = - 0.634, P = 0.016). Receiver operating characteristic curve analysis showed that serum GAPDH and GLO1 could predict the risk of ACS in T2DM patients.
Conclusion: These findings revealed that high carbonyl stress due to lower levels of GAPDH and GLO1 may predispose patients with T2DM for more risk of ACS.
Competing Interests: Declaration of competing interest I, Dr. Prashant Shankarrao Adole, declare that I or other authors have no proprietary, financial, professional or other personal interest of any nature or kind in any product, service and/or company that could be constructed as influencing the position presented in, or the review of, the manuscript entitled “Association between carbonyl stress markers and the risk of acute coronary syndrome in patients with type 2 diabetes mellitus – A pilot study.”
(Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: